|1.||Johnston, Thomas P: 11 articles (03/2013 - 06/2003)|
|2.||Cho, Chong-Su: 6 articles (01/2013 - 02/2006)|
|3.||Song, Cunxian: 6 articles (06/2010 - 01/2009)|
|4.||Mei, Lin: 5 articles (06/2010 - 01/2009)|
|5.||Sun, Hongfan: 5 articles (06/2010 - 01/2009)|
|6.||Choi, Han-Gon: 4 articles (12/2015 - 08/2005)|
|7.||Korolenko, T A: 4 articles (11/2015 - 06/2013)|
|8.||Oh, Se Heang: 4 articles (01/2014 - 03/2005)|
|9.||Lee, Jin Ho: 4 articles (01/2014 - 03/2005)|
|10.||Brocks, Dion R: 4 articles (01/2013 - 01/2006)|
|1.||Wounds and Injuries (Trauma)
08/01/2008 - "Poloxamer 188 (P188), a nonionic block copolymer chemical surfactant known to have cytoprotective, rheologic, anti-inflammatory, and anti-thrombotic activity, has shown promise in the management of selected trauma patients. "
08/16/2007 - "The wound healing efficacy of CS/poloxamer SIPNs as a wound dressing was evaluated on experimental full thickness wounds in a mouse model. "
05/01/2012 - "In this study, intradermal treatment of excisional wounds of stressed mice with 2mg/ml KSLW loaded in Pluronic F68, resulted in a sustained antimicrobial effect through post-operative day 5, with a 2-log (p<0.01) reduction in bacterial load compared with other stressed mice. "
10/01/2015 - "The gel-treated and SA-treated wounds received topically 400 μl of pluronic F-127 gel (25%) and 400 μl of SA (0.3%) in pluronic gel, respectively, once daily for 19 days. "
12/01/2014 - "Therefore, our results suggest that NaB, and its pluronics combination, could be used in dermatological clinics and be a future solution for chronic wounds. "
01/01/2015 - "A functional drug delivery platform for targeting and imaging cancer cells based on Pluronic F127."
05/01/2012 - "Viral injection in SELP 815K produced a greater level and more prolonged extent of gene expression in the tumor, a statistically greater tumor size reduction, a longer time until tumor rebound, and a significantly increased survivability, as compared to injection of virus alone or in Poloxamer 407. "
02/01/2012 - "The LMw MC gel/Pluronic F127 micelle combination system constitutes a promising tool for reducing tumor size and eradicating remaining tumor cells before and after surgery."
04/01/2011 - "Poly(diethylaminoethylmethacrylate) (PDEAEM) and Pluronic F127 based pentablock copolymer vectors with the ability to transfect cancer cells selectively over normal cells in in vitro cultures were developed, as described in a previous report. "
04/01/2011 - "Previous work demonstrated that the poly(diethylaminoethylmethacrylate) (PDEAEM)/Pluronic F127 pentablock copolymers exhibit transfection in vitro selectively in cancer cell lines as opposed to non-cancerous cell lines. "
08/01/1996 - "Poloxamer 188-treated patients demonstrated a 38% reduction in median myocardial infarct size (25th and 75th percentile) compared with placebo (16% [7, 30] versus 26% [9, 43]; P = .031), greater median myocardial salvage (13% [7, 20] versus 4% [1, 15]; P = .033), and a 13% relative improvement in median ejection fraction (52% [43, 60] versus 46% [35, 60]; P = .020). "
12/01/1994 - "A 48-hour infusion of poloxamer 188 reduced myocardial infarct size and improved left ventricular function in this dog model of 90 minutes of coronary artery occlusion and 72 hours of reperfusion. "
08/01/2000 - "Mortality and reinfarction rate were measured in 2770 patients with acute myocardial infarction who received thrombolysis within 12 hours in CORE, an international, dose ranging trial of poloxamer 188. "
04/01/1998 - "RheothRx injection is an intravenous formulation of Poloxamer 188, a non-ionic block copolymer surfactant which is actually used in clinical studies, e.g., during thrombolysis in acute myocardial infarction. "
07/01/1997 - "Previous studies suggested that RheothRx (poloxamer 188) reduces infarct size and improves left ventricular (LV) function in acute myocardial infarction (AMI). "
02/01/2015 - "Poloxamer 188 (P188) has also proven beneficial to neuronal and cardiac tissue during reperfusion injury in human and animal models. "
01/01/2013 - "Poloxamer 188 protects neurons against ischemia/reperfusion injury through preserving integrity of cell membranes and blood brain barrier."
06/01/2010 - "The authors postulated that a single-dose administration of poloxamer 188 would decrease skeletal myocyte injury and mortality following ischemia-reperfusion injury. "
06/01/2010 - "Poloxamer 188 protects against ischemia-reperfusion injury in a murine hind-limb model."
01/01/2010 - "Poloxamer 188 inhibition of ischemia/reperfusion injury: evidence for a novel anti-adhesive mechanism."
11/01/2011 - "The surfactant poloxamer 188 (P188) has been shown to improve survival following hemorrhage. "
07/01/1994 - "It is postulated that poloxamer 188 would improve outcome if administered during retransfusion following hemorrhage. "
03/01/2010 - ": To check the efficacy of a reverse thermosensitive gel (poloxamer P407) for intracoronary shunt sealing in off-pump coronary artery bypass surgery to stop residual bleeding from the shunt and avoid the use of blowers. "
11/01/2011 - "Severe controlled hemorrhage resuscitation with small volume poloxamer 188 in sedated miniature swine."
01/01/2007 - ": To evaluate a new material, poloxamer 407 reverse-thermal polymer, which may be of value in controlling bleeding during off-pump coronary anastomoses. "
|1.||Poloxamer (Poloxamer 407)
|2.||UCON 50-HB-5100 (F127)
|4.||alginic acid (sodium alginate)
|2.||Drug Therapy (Chemotherapy)
|3.||Angioplasty (Angioplasty, Transluminal)